Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AbCellera Biologics Inc (ABCL) vs iShares 7-10 Year Treasury Bond ETF (IEF) Price & Performance

AbCellera Biologics IncTrade
iShares 7-10 Year Treasury Bond ETFTrade

Price performance (Past 24H)

Key statistics

AbCellera Biologics Inc vs iShares 7-10 Year Treasury Bond ETF — how do they compare? AbCellera Biologics Inc trades at $8.95 (market cap $2.99B), while iShares 7-10 Year Treasury Bond ETF trades at $92.9. The key difference: AbCellera Biologics Inc is trading nearer its 52-week high, iShares 7-10 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.

ABCLIEF
Market Cap
$2.99B
Sector
Health
52-Week High
$9.76$97.99
52-Week Low
$2.78$92.76
Enterprise Value
$2.58B

Returns comparison

Trailing returns across standard periods

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Read more on ABCL

About iShares 7-10 Year Treasury Bond ETF

The underlying index measures the performance of public obligations of the US Treasury that have a remaining maturity of greater than or equal to seven years and less than ten years. The fund will invest at least 80% of its assets in the component securities of the underlying index, and the fund will invest at least 90% of its assets in US Treasury securities that the advisor believes will help the fund track the underlying index.

Read more on IEF